Page last updated: 2024-08-23

haloperidol decanoate and Cardiovascular Diseases

haloperidol decanoate has been researched along with Cardiovascular Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tagne Nouemssi, AB1

Other Studies

1 other study(ies) available for haloperidol decanoate and Cardiovascular Diseases

ArticleYear
Risperidone-associated sinus tachycardia potentiated by paliperidone palmitate in a patient with no prior cardiovascular disease: role of risperidone-related autonomic instability.
    BMJ case reports, 2018, Apr-21, Volume: 2018

    Topics: Antipsychotic Agents; Autonomic Nervous System; Cardiovascular Diseases; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Therapy, Combination; Haloperidol; Humans; Male; Paliperidone Palmitate; Risperidone; Schizophrenia; Tachycardia, Sinus; Treatment Outcome; Young Adult

2018
chemdatabank.com